Search Prime Grants

HT94252310454

Project Grant

Overview

Grant Description
Ampk-Activator Metformin to Promote Podocyte Survival in FSGS: A Pilot Trial
Awardee
Yale Univ
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
New Haven, Connecticut 065118917 United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Yale Univ was awarded Promoting Podocyte Survival in FSGS: Ampk-Activator Metformin Pilot Trial Project Grant HT94252310454 worth $4,774,516 from Defense Health Agency in June 2023 with work to be completed primarily in New Haven Connecticut United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 1/17/24

Period of Performance
6/1/23
Start Date
5/31/27
End Date
62.0% Complete

Funding Split
$4.8M
Federal Obligation
$0.0
Non-Federal Obligation
$4.8M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252310454

Subgrant Awards

Disclosed subgrants for HT94252310454

Transaction History

Modifications to HT94252310454

Additional Detail

Award ID FAIN
HT94252310454
SAI Number
None
Award ID URI
None
Awardee Classifications
Private Institution Of Higher Education
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
FL6GV84CKN57
Awardee CAGE
4B992
Performance District
CT-03
Senators
Richard Blumenthal
Christopher Murphy

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $4,774,516 100%
Modified: 1/17/24